Cargando…
An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Treatment options for Crohn’s disease have evolved beyond the early goals of induction and remission and are now more focused on preventing complications by altering the natural history of the disease. The advent of biologic therapies has revolutionized the management of Crohn’s disease. Specificall...
Autores principales: | Edula, Raja GR, Picco, Michael F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789688/ https://www.ncbi.nlm.nih.gov/pubmed/20011247 |
Ejemplares similares
-
Natalizumab in the treatment of Crohn’s disease
por: Guagnozzi, Danila, et al.
Publicado: (2008) -
Natalizumab in Crohn's disease: past and future areas of applicability
por: Armuzzi, Alessandro, et al.
Publicado: (2013) -
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program
por: Chen, Chien-Huan, et al.
Publicado: (2013) -
Natalizumab in Multiple Sclerosis: Long-Term Management
por: Clerico, Marinella, et al.
Publicado: (2017) -
Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)